2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
2
Neoplasms
2
Urinary Tract Infections
1
Tuberculosis, Pulmonary
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Patient Satisfaction
1
Neutropenia
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Lung Neoplasms
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Infections
1
Hypoxia
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Interventions
Surveys and Questionnaires
3
delta 24-sterol reductase
2
Urinary Diversion
2
Surgical Procedures, Operative
2
Propofol
2
daratumumab
1
Vascular Access Devices
1
Uterine Artery Embolization
1
Tranexamic Acid
1
Telemedicine
1
Pilot Projects
1
Patient Transfer
1
Parapsychology
1
Music Therapy
1
Midazolam
1
Mastectomy, Segmental
1
Lidocaine
1
Lead
1
Imiquimod
1
Ibuprofen
1
Fentanyl
1
Exercise
1
Drainage
1
Cystectomy
1
Control Groups
1
Colonoscopy
1
Bandages, Hydrocolloid
1
Anesthesia, Local
1
Ambulatory Care
1
Alfentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patient Satisfaction
×
Alfentanil
×
Clear all
NCT05688384
2024-11-12
PACSPI-2
Region Jönköping County
Phase 4
Completed
340 enrolled